BioTek Instruments is proud to announce that President and CEO Briar Alpert was named to the Board of Trustees at the University of Vermont (UVM) as of March 1, 2016.

As part of this six-year term, Mr. Alpert will advise and support UVM management on policy, budgets, strategic planning and other matters to ensure the University’s long-term vision and success.

Mr. Alpert has far-reaching ties with the University, having earned his MBA and a BS in mechanical engineering from UVM. Additionally, his father and BioTek’s founder, Dr. Norman Alpert, was an internationally recognized expert in cardiac hypertrophy and energetics while serving as Chairman of the Physiology Department at the University of Vermont Medical College.

Along with the UVM Board of Trustees, Mr. Alpert is the Vice Chairman & Chairman-Elect for the Analytical, Life Science & Diagnostics Association (ALDA), a Charter Member and Director of the Vermont Center of Emerging Technologies (VCET), and is a full member of the Vermont Academy of Science and Engineering (VASE) and Mechanical Engineering Honor Society.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. As such, they are often honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, North American New Product Innovation Award for Workflow Solutions in Life Sciences and Drug Discovery Product of the Year – Scientists' Choice Award.

more about biotek

more news from biotek